Overweight, obese young men at increased risk of liver disease

(Reuters Health) - Young men who are overweight or obese have up to double the risk of normal-weight peers for developing liver disease later in life, a large study in Sweden suggests.

U.S. Zika vaccine begins second phase of testing

CHICAGO (Reuters) - Researchers have begun the second phase of testing of a Zika vaccine developed by U.S. government scientists in a trial that could yield preliminary results as early as the end of 2017.

Biogen wins Tecfidera U.S. patent dispute with Forward Pharma

(Reuters) - A U.S. patent board on Friday ruled against Danish drugmaker Forward Pharma A/S, finding Biogen's patents on its blockbuster multiple sclerosis drug Tecfidera to be valid.